Investor wants GSK to consider consumer sale

2 July 2021 - Deborah Wilkes

Premium

Activist investor Elliott Investment Management is urging GlaxoSmithKline (GSK) to consider selling its Consumer Healthcare business rather than going ahead with the proposed separation.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: